Navy Seal pens book on Osama bin Laden raid

August 24, 2012

No_Easy_Day

Washington, August 24: The US government was surprised by the news that a navy Seal who participated in the raid on Osama bin Laden's compound in Pakistan has written a book about the operation in which the al-Qaida leader was killed, US officials said on Wednesday.


'No Easy Day: The Firsthand Account of the Mission that Killed Osama bin Laden' was written by a navy Seal under the pseudonym Mark Owen with co-author Kevin Maurer and is to be released next month on the anniversary of the September 11 attacks. It was not vetted by government agencies to ensure that no secrets were revealed.


However, Christine Ball, a spokeswoman for the publisher , Dutton, said, "The book was vetted by a former special operations attorney. He vetted it for tactical, technical, and procedural information as well as information that could be considered classified by compilation and found it to be without risk to national security."

The book will be published at a time when Washington has been roiled by controversy over national security leaks ahead of the November 6 presidential election. Republicans have charged that President Barack Obama's administration has engaged in selective leaks to bolster the Democrat's national security credentials. The White House denies those accusations. 0But the book on the bin Laden raid appeared to catch officials off guard.

"We learned about this book on Thursday from press reports. We haven't reviewed it and don't know what it says," White House spokesman Tommy Vietor said. The Pentagon said it hadn't vetted the book or helped provide information to the authors. There are at least two Pentagon regulations requiring the defence department review writings by retired troops that contain sensitive material.



Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 8,2024

covid.jpg

AstraZeneca said on Tuesday it had initiated the worldwide withdrawal of its COVID-19 vaccine due to a "surplus of available updated vaccines" since the pandemic.

The company also said it would proceed to withdraw the vaccine Vaxzevria's marketing authorizations within Europe.

"As multiple, variant Covid-19 vaccines have since been developed there is a surplus of available updated vaccines," the company said, adding that this had led to a decline in demand for Vaxzevria, which is no longer being manufactured or supplied.

According to media reports, the Anglo-Swedish drugmaker has previously admitted in court documents that the vaccine causes side-effects such as blood clots and low blood platelet counts.

The firm's application to withdraw the vaccine was made on March 5 and came into effect on May 7, according to the Telegraph, which first reported the development.

London-listed AstraZeneca began moving into respiratory syncytial virus vaccines and obesity drugs through several deals last year after a slowdown in growth as COVID-19 medicine sales declined.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.